Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (391-400 of 451) with videos related to

Pageof 46
Sort By:
European Heart Journal|October 2, 2015
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillationEmily C O'Brien, DaJuanicia N Simon, Laine E Thomas, et al.
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
American Heart Journal|June 22, 2015
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registrySean D Pokorney, DaJuanicia N Simon, Laine Thomas, et al.
The American Journal of Cardiology|March 9, 2019
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)Sreekanth Vemulapalli, Taku Inohara, Sunghee Kim, et al.
American Heart Journal|November 6, 2018
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart StudyMintu P Turakhia, Manisha Desai, Haley Hedlin, et al.
Circulation. Cardiovascular Quality and Outcomes|November 13, 2014
Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF)Andrew C T Ha, Günter Breithardt, A John Camm, et al.
Pageof 46

Showing results (391-400 of 451) with videos related to

Sort By:
Pageof 46
European Heart Journal|October 2, 2015
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillationEmily C O'Brien, DaJuanicia N Simon, Laine E Thomas, et al.
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Heart Journal|April 21, 2009
Assessing proarrhythmic potential of drugs when optimal studies are infeasibleEdwin P Rock, John Finkle, Howard J Fingert, et al.
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
American Heart Journal|June 22, 2015
Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registrySean D Pokorney, DaJuanicia N Simon, Laine Thomas, et al.
The American Journal of Cardiology|March 9, 2019
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)Sreekanth Vemulapalli, Taku Inohara, Sunghee Kim, et al.
American Heart Journal|November 6, 2018
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart StudyMintu P Turakhia, Manisha Desai, Haley Hedlin, et al.
Circulation. Cardiovascular Quality and Outcomes|November 13, 2014
Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF)Andrew C T Ha, Günter Breithardt, A John Camm, et al.
Pageof 46